Pulse Biosciences
PLSE
27 hedge funds and large institutions have $8.06M invested in Pulse Biosciences in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 4 closing their positions.
4,369% more call options, than puts
Call options by funds: $1.43M | Put options by funds: $32K
25% more capital invested
Capital invested by funds: $6.43M → $8.06M (+$1.63M)
0.1% less ownership
Funds ownership: 6.61% → 6.5% (-0.1%)
7% less funds holding
Funds holding: 29 → 27 (-2)
40% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 10
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$12K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.6K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$11.3K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$8.85K |
| 5 |
BlackRock
New York
|
+$3.38K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WIM
Westside Investment Management
Santa Monica,
California
|
-$83K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$74K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$41.2K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$33.2K |
| 5 |
Millennium Management
New York
|
-$32.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Citadel Advisors
Miami,
Florida
| $44 | -$74K | -24,552 | -100% |
|
|
27
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$41.2K | -13,650 | Closed |
|
28
Simplex Trading
Chicago,
Illinois
| – | -$27.8K | -9,202 | Closed |
|
29
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| – | -$3K | -1,050 | Closed |
|
PLSE Hedge Fund Activity: Q1 2023 in Review
27 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q1 2023, worth a combined $8.06M — up 25% from $6.43M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of PLSE and 2 opened new positions — a net loss of 2 holders — while 10 trimmed existing stakes and 6 added.
The largest buyer was Bank of America, adding an estimated $12K. The largest seller was Westside Investment Management, cutting an estimated $83K.
- 27 institutional investors held Pulse Biosciences (PLSE) as of Q1 2023, down from 29 in Q4 2022.
- Funds reported $8.06M of Pulse Biosciences stock for Q1 2023, up 25% quarter-over-quarter.
- 2 funds opened new Pulse Biosciences positions in Q1 2023 and 4 closed out, a net change of -2 holders.
- The largest Pulse Biosciences buyer in Q1 2023 was Bank of America, an estimated $12K added.
- The largest Pulse Biosciences seller in Q1 2023 was Westside Investment Management, an estimated $83K sold.
Based on aggregated 13F filings for Q1 2023.